Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Pharma Industry Stares Down Biggest Patent Cliff in Decades
Most companies sell a hit product for as long as customers want it. For drugmakers, a clock starts before a drug is even approved: Patents run out, lower-priced copycats flood in and sales collapse. Billions of dollars of annual sales can…
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Company announcement – No. 43 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, August 28, 2026 –…
FDA cancels Cipla pharma's CFA drug sale licence in Pune
The Maharashtra Food and Drug Administration (FDA) cancelled the carry and forwarding agent (CFA) drug sale licence of Cipla Pharma & Life Sciences Ltd, Vadki, Pune. During an inspection conducted in June this year, FDA officials found…
Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Govt
Argentina has committed to reduce barriers to facilitate entry of Indian pharmaceutical sector in the South American nation, the commerce ministry said on Saturday. This is expected to provide greater opportunities for Indian pharmaceutical…
FDA cancels drug sale licences of Cipla Pharma & Life Sciences' Pune Carry and Forwarding unit
The Maharashtra Food and Drug Administration has cancelled the drug sale licences of Cipla Pharma & Life Sciences Ltd's Carry and Forwarding (C&F) unit in Pune over serious irregularities related to the packaging, storage and recall of Reactin Plus…
Maharashtra FDA crackdown on Cipla Pharma's Pune unit, cancels licence over 'unauthorised promotional text' on Reactin Plus
The Maharashtra Food and Drug Administration (FDA) has cancelled the drug sale licences of Cipla Pharma & Life Sciences Ltd's Carry and Forwarding (C&F) facility at Wadki in Pune, citing serious irregularities found during inspections linked to…
Deutsche Bank AG Takes $1.90 Million Position in Urogen Pharma $URGN
Deutsche Bank AG acquired a new position in shares of Urogen Pharma (NASDAQ:URGN - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 51,550 shares of the…
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives Average Rating of 'Moderate Buy' from Analysts
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) has earned a consensus recommendation of 'Moderate Buy' from the twenty-three brokerages that are presently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a…
Why won't the legacy media cover Big Pharma properly anymore?
“It is difficult to get a man to understand something when his salary depends on his not understanding it.” The muckraking journalist Upton Sinclair wrote those words in 1934. Truer words have never been spoken; I made them the…
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Up 6% - Here's What Happened
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report)'s share price rose 6% during trading on Friday. The company traded as high as $17.92 and last traded at $17.92. Approximately 302 shares were traded during…
Jefferies Financial Group Inc. Buys New Position in Urogen Pharma $URGN
Jefferies Financial Group Inc. acquired a new position in Urogen Pharma (NASDAQ:URGN - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired…
BioNTech, Roche Scrap Cancer Vaccine Trial in Blow to New Field
BioNTech SE and Roche Holding AG abandoned a trial of a personalized cancer vaccine, dashing hopes that had been raised by a rival drugmaker's recent success in the same field. The German biotech and its Swiss pharma partner took the decision after…
BioCryst is profitable. Now it wants to buy more rare disease drugs
BioCryst expects up to $645 million in 2026 sales from its HAE drug Orladeyo, giving it capital to pursue external deals. As large drugmakers prioritize multibillion dollar assets, small and midsize biotech companies are increasingly stepping in to…
Maharashtra FDA Cancels Cipla Pune Unit's Drug Licence Over Reactin Plus Lapses
Mumbai: The Maharashtra Food and Drug Administration (FDA) has cancelled the drug sale licences of Cipla Pharma & Life Sciences Ltd's Carry and Forwarding (C&F) unit in Pune over multiple regulatory violations linked to Reactin Plus Tablets…
Walmart settles US government's opioid lawsuit
Walmart has settled a United States government lawsuit accusing the largest US retailer of fueling a nationwide opioid epidemic by unlawfully dispensing prescriptions from its pharmacies. The US Department of Justice and Walmart confirmed the…
Receive a Daily briefing on Pharma Industry News
Get Started